pharmaphorum

FDA clears first all-oral combo for first-line CLL treatment

The combination of AstraZeneca's Calquence and AbbVie/Roche's Venclexta has become the first all-oral, fixed-duration regimen for patients with newly-diagnosed chronic lymphocytic leukaemia (CLL) in ...
Investing

Gilead reports positive phase 3 data for HIV treatment combo

FOSTER CITY, Calif. - Gilead Sciences Inc. (NASDAQ:GILD) presented Phase 3 trial results for an investigational single-tablet combination of bictegravir 75 mg and lenacapavir 50 mg for HIV treatment ...
autoevolution

Glorious Gold Classic Pontiac GTO Convertible Packs Upgraded 455 Motor, Original Rag Top

Is there anything better in life than a well-sorted late ‘60s Pontiac GTO with a convertible rag top? The hard top coupe is nice and all, but adding the wind in your hair to the sound of of a big ...
Investing

Calquence combo wins FDA approval for blood cancer treatment

UNITED STATES - AstraZeneca (LSE:AZN) received U.S. Food and Drug Administration approval for Calquence in combination with venetoclax as a treatment for adult patients with chronic lymphocytic ...